NCT01788670

Brief Summary

Health benefits for humans derived from low dose intake of ethanol could partially be explained by its interaction with dopamine (DA) oxidative metabolism. Ethanol is expected to induce an increase in the formation of a DA minor metabolite: DOPET (hydroxytyrosol). Hydroxytyrosol is one of the most potent antioxidants present in Mediterranean Diet. The study is aimed at establishing the contribution of ethanol on hydroxytyrosol formation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started May 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

February 5, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 11, 2013

Completed
Last Updated

February 11, 2013

Status Verified

February 1, 2013

Enrollment Period

1.1 years

First QC Date

February 5, 2013

Last Update Submit

February 7, 2013

Conditions

Keywords

Antioxidants, Central Nervous System Agents

Outcome Measures

Primary Outcomes (1)

  • Hydroxytyrosol biological fluids concentrations

    Hydroxytyrosol concentrations in plasma and urine

    0-24h after administration

Secondary Outcomes (5)

  • Subjective drunkenness

    0-6h after administration

  • Vital signs

    0-6h after administration

  • Ethanol concentration

    0-6h after administration

  • Ethanol metabolites concentrations

    0-24h after administration

  • Dopamine metabolites concentrations

    0-24h after administration

Study Arms (3)

Water

PLACEBO COMPARATOR

Lemon-flavoured water (150 ml)

Other: Water

Ethanol high dose

ACTIVE COMPARATOR

The high dose corresponds to 30 g of ethanol in pilot cohort 1, to 12 g of ethanol in pilot cohort 2 and to 42 g of ethanol in pilot cohort 3. For the definitive study the high dose corresponds to 30 g of ethanol. Ethanol was administered as a single dose of pure ethanol diluted in lemon-flavoured water (150 ml each beverage).

Dietary Supplement: Ethanol

Ethanol low dose

ACTIVE COMPARATOR

The low dose corresponds to 18 g of ethanol in pilot cohort 1, to 6 g of ethanol in pilot cohort 2 and to 24 g of ethanol in pilot cohort 3. For the definitive study the low dose corresponds to 18 g of ethanol. Ethanol was administered as a single dose of pure ethanol diluted in lemon-flavoured water (150 ml each beverage).

Dietary Supplement: Ethanol

Interventions

EthanolDIETARY_SUPPLEMENT
Ethanol high doseEthanol low dose
WaterOTHER
Water

Eligibility Criteria

Age18 Years - 55 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical history and physical examination demonstrating no organic or psychiatric disorders.
  • The ECG and general blood and urine laboratory tests performed before the study should be within normal ranges. Minor or occasional changes from normal ranges are accepted if, in the investigator's opinion, considering the current state of the art, they are not clinically significant, are not life-threatening for the subjects and do not interfere with the product assessment. These changes and their non-relevance will be justified in writing specifically.
  • The body mass index (BMI=weigh/height2) will range from 19 to 27 kg/m2, and the weight from 50 to 110 kg.
  • Understanding and accepting the study procedures and signing the informed consent.

You may not qualify if:

  • History or clinical evidence of alcoholism, drug abuse, or regular use of psychoactive drugs.
  • Having suffered any organic disease or major surgery in the three months prior to the study start.
  • History of psychiatric disorders.
  • Smokers of more than 20 cigarettes per day.
  • Taking more than 30 g of alcohol a day
  • Blood donation 8 weeks before or participation in other clinical trials with drugs in the previous 12 weeks.
  • Subjects with intolerance or adverse reactions to ethanol
  • History or clinical evidence of gastrointestinal, liver, renal or other disorders which may lead to suspecting a disorder in drug absorption, distribution, metabolism or excretion, or that suggest gastrointestinal irritation due to drugs.
  • Subjects unable to understand the nature, consequences of the study and the procedures requested to be followed.
  • Subjects with positive serology to Hepatitis B, C or HIV.
  • To be eligible, the subjects must agree to follow a diet free from ethanol and olive oil in the 72 hours prior to the start of each session and until the end of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parc de Salut Mar

Barcelona, Barcelona, 08003, Spain

Location

Related Publications (1)

  • Perez-Mana C, Farre M, Pujadas M, Mustata C, Menoyo E, Pastor A, Langohr K, de la Torre R. Ethanol induces hydroxytyrosol formation in humans. Pharmacol Res. 2015 May-Jun;95-96:27-33. doi: 10.1016/j.phrs.2015.02.008. Epub 2015 Mar 20.

MeSH Terms

Interventions

EthanolWater

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Magí Farré, MD, PhD

    Parc de Salut Mar

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2013

First Posted

February 11, 2013

Study Start

May 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

February 11, 2013

Record last verified: 2013-02

Locations